Breaking News

JLL Partners To Invest in Patheon

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Patheon, Inc. has entered into a definitive agreement with JLL Partners, under which JLL will purchase $150 million of Patheon shares. The transaction, subject to shareholder approval and customary closing conditions, is targeted to close by April 30, 2007. Patheon plans to use the investment proceeds (approximately $138 million) towards its outstanding debt of $238 million under its existing North American credit facilities. “This investment will establish a stronger financial f...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters